ConductScience.org, home
Papers
API referenceFor AI assistants

Paper67211

Serologic identification of multiple tumor-associated antigens on murine sarcomas.

Parker GA and 1 other. J Natl Cancer Inst, 1977. Cited by 88 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Serologic identification of multiple tumor-associated antigens on murine sarcomas. Papers, record 67211. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/67211

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Serologic identification of multiple tumor-associated antigens on murine sarcomas.
PubMed
Journal
J Natl Cancer Inst
PubMed
Year
1977
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
88
iCite
Relative citation ratio, by iCite
2.05
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Parker GAG A
2Rosenberg SAS A

Source PubMed

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Sarcoma, ExperimentalMajor topic
Animals
Antibodies, Neoplasm
Antibody Formation
Antibody Specificity
Cell Membrane
Cross Reactions
Cytotoxicity Tests, Immunologic
Epitopes
Female
Methylcholanthrene
Mice
Mice, Inbred C57BL

Source PubMed

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 88 citations.

PMIDTitleJournalYearIn PapersSource
25,189,717Cancer immunotherapy in clinical practice -- the past, present, and future.Chin J Cancer2014https://conductscience.org/library/papers/25189717PubMed
8,915,492Improved in vivo efficacy of tumor-infiltrating lymphocytes after restimulation with irradiated tumor cells in vitro.Ann Surg Oncol1996https://conductscience.org/library/papers/8915492PubMed
8,425,207Antitumor effects of recombinant interleukin-6 expressed in eukaryotic cells.Cancer Immunol Immunother1993https://conductscience.org/library/papers/8425207PubMed
6,984,355Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor.Cancer Immunol Immunother1982https://conductscience.org/library/papers/6984355PubMed
6,980,254Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2.J Exp Med1982https://conductscience.org/library/papers/6980254PubMed
3,594,490Synergistic antitumor activity of cyclophosphamide and ABPP in the treatment of established and advanced tumors in murine tumor models.Cancer Immunol Immunother1987https://conductscience.org/library/papers/3594490PubMed
3,383,204Antitumor effect of recombinant tumor necrosis factor-alpha against murine sarcomas at visceral sites: tumor size influences the response to therapy.Cancer Immunol Immunother1988https://conductscience.org/library/papers/3383204PubMed
3,264,714Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model.Br J Cancer1988https://conductscience.org/library/papers/3264714PubMed
3,257,900In vivo generation of lymphokine activated killer cell activity by ABPP and interleukin-2 and their antitumor effects against immunogenic and nonimmunogenic tumors in murine tumor models.Cancer Immunol Immunother1988https://conductscience.org/library/papers/3257900PubMed
2,598,182Studies of the mechanisms of toxicity of the administration of recombinant tumor necrosis factor alpha in normal and tumor-bearing mice.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2598182PubMed
2,452,015Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells.Cancer Immunol Immunother1988https://conductscience.org/library/papers/2452015PubMed
2,307,930Antitumor activity of recombinant interleukin 6 in mice.J Exp Med1990https://conductscience.org/library/papers/2307930PubMed
475,970Tissue distribution and biochemical properties of an interspecific tumour-associated gamma foetal antigen.Br J Cancer1979https://conductscience.org/library/papers/475970PubMed
93,484Partial purification of tumour-specific transplantation antigens from methylcholanthrene-induced murine sarcomas by immobilized lectins.Br J Cancer1979https://conductscience.org/library/papers/93484PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/67211

GET https://conductscience.org/api/papers/v1/67211/authors

API referenceFor AI assistants